Global smart insulin pens market is anticipated to grow at a CAGR of 10.0% during the forecast period (2024-2031). A major factor supporting the growth of the market is the increasing advancements in healthcare technologies by various companies, which in turn is bolstering investments in the smart insulin pens market. Such investments are also backed by the increased prevalence of diabetes globally.
For instance, in November 2022, Eli Lilly and Co. rolled out its first connected platform, the Tempo personalized diabetes management platform in the US. The technology aims to help adults living with type 1 or type 2 diabetes and informs clinicians with the updated, data-backed decisions to manage treatment with Lilly insulins. The platform consists of three key components the Tempo Smart Button a compatible app, TempoSmart, and a prefilled insulin pen.
Browse the full report description of “Smart Insulin Pens Market Size, Share & Trends Analysis Report by Connectivity Type (Bluetooth and NFC (Near-Field Communication)), by Indication (Type 1 Diabetes and Type 2 Diabetes), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and E-Commerce) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/smart-insulin-pens-market
In September 2023, Medtronic plc MDT received Conformite Europeenne (CE) Mark approval for its new Simplera Continuous Glucose Monitor (CGM). It is under review by the Food and Drug Administration (FDA) and is limited to investigational use in the US. This latest addition of a Smart Multiple Daily Injection (MDI) solution will boost Medtronic’s Diabetes Operating Unit. However, in October 2023, the company announced to commercial launch the product Simplera CGM at the European Association for the Study of Diabetes 59th Annual Meeting in Hamburg, Germany.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Connectivity Type
o By Indication
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Novo Nordisk A/S, SANOFI, Insulet Corp., Crunchbase, and Medtronic Private Limited among others.
Key questions addressed by the report.
Global Smart Insulin Pens Market Report Segment
By Connectivity Type
By Indication
By Distribution Channel
Global Smart Insulin Pens Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• The Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/smart-insulin-pens-market